Home › Funds › ADVOCATE GROUP LLC › ABBV

ADVOCATE GROUP LLC position in ABBV

ABBVIE INC · Health Care

ADVOCATE GROUP LLC reported holding 67,923 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$17.8M, representing 2.75% of its reported portfolio and ranking #3 among its reported holdings. ADVOCATE GROUP LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)67.92K sh
Reported value held$17.77M
Portfolio Weight2.75%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How ADVOCATE GROUP LLC's ABBV position evolved

ADVOCATE GROUP LLC first disclosed a stake in ABBV in Q3 2023 at 79,223 shares (US$11.8M). The position peaked in Q3 2025 at 82,247 shares, worth US$19.0M. Across 13 filings, ADVOCATE GROUP LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 67,923 shares valued at US$17.8M — a reduction of -7,144 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 79.22K $11.81M New
Q4 2023 78.21K $12.12M Reduce
Q1 2024 77.40K $14.09M Reduce
Q2 2024 77.00K $13.21M Reduce
Q3 2024 77.29K $15.26M Hold
Q4 2024 77.95K $13.85M Add
Q1 2025 79.14K $16.58M Add
Q2 2025 81.30K $15.09M Add
Q3 2025 82.25K $19.04M Add
Q4 2025 76.21K $17.41M Reduce
Q1 2026 75.67K $16.46M Reduce
Q2 2026 75.07K $18.89M Reduce
Q3 2026 67.92K $17.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has ADVOCATE GROUP LLC held ABBV?

ADVOCATE GROUP LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ADVOCATE GROUP LLC's current position in ABBV?

As of Q3 2026, ADVOCATE GROUP LLC holds 67.92K shares of ABBV (ABBVIE INC), valued at $17.77M, representing 2.75% of its reported portfolio and ranking #3.

Has ADVOCATE GROUP LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), ADVOCATE GROUP LLC reduced its position in ABBV. The position peaked in Q3 2025 at 82.25K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.